<qa>  What type of therapy should patients continue on?2. Patient has histologically-confirmed advanced andor metastatic AI-PCa requiring anti-neoplastic treatment. Patients should continue on LHRH analog therapy throughout the study period, if this is their mode of androgen suppression therapy. Patients should have discontinued anti-androgen therapy for than 4 weeks for flutamide or 6 weeks for bicalutamide and nilutamide. 